HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dove Defies Pessimistic “Anti-Aging” Ideology With New Pro-Age Line

This article was originally published in The Rose Sheet

Executive Summary

Dove is "breaking tradition and challenging stereotypes" - encouraging menopausal women to embrace their age - with pro-age, a complete line of personal care products launching in February

You may also be interested in...



Care2 Petitions Top Beauty Firms To Call 'Anti-Aging' Products … Something Else

An online petition launched through B Corp social network Care2 urges Estee Lauder and L’Oreal to remove the term “anti-aging” from their products and marketing in favor or more age-positive language. The appeal follows beauty magazine Allure’s recent commitment to stop using the term, which it says negatively suggests “that aging is a condition we need to battle.”

Unilever Looks To Emerging Markets, Vitality Brands For 2008 Growth

Unilever will focus on emerging markets and "vitality" brands that enhance consumers' quality of life in order to grow revenue in 2008, the firm says in its annual report, released March 29

Unilever Looks To Emerging Markets, Vitality Brands For 2008 Growth

Unilever will focus on emerging markets and "vitality" brands that enhance consumers' quality of life in order to grow revenue in 2008, the firm says in its annual report, released March 29

Latest News
See All
UsernamePublicRestriction

Register

RS014491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel